This article is more than 5 years old. Information may no longer be current.

African-Americans with mycosis fungoides had poorer survival

African-Americans with mycosis fungoides experienced poorer overall survival than white or Asian patients, according to recent findings.

The researchers studied data from 4,459 patients with mycosis fungoides in the U.S. National Cancer Database between 2004 and 2014. They suggested that prior data had shown conflicting results on the role of race on outcomes in this disease.

The study population was 77.7% white, 19.2% African-American, and 3.2% Asian.

Multivariate analysis results indicated that African-American race was a predictor of poorer overall survival (P < .001). Other predictors of poor overall survival included older age, treatment in a community facility, government insurance, higher Charlson-Deyo score, being male, higher clinical stage, and receipt of radiotherapy or chemotherapy, according to the findings.

Improved outcomes were reported among Asians (P = .07). – by Rob Volansky

Disclosure: The researchers report no relevant financial disclosures.